Sign In

Michael Hull

President

Michael Hull is the President of nVector, Inc., a biotechnology company focused on central nervous system (CNS) gene therapies and diagnostics. He has extensive experience in financial and operational support for start-ups, with a particular focus on commercializing scientific discoveries.12

Professional Background:

  • Co-founded InVent Life Sciences, a commercialization company for life science discoveries
  • Experienced in building operational infrastructure for technology companies
  • Helps research teams commercialize their scientific innovations1

Current Role: Hull serves as President of nVector (formerly Iron Horse Diagnostics), a company that provides:

  • CNS gene therapy technologies
  • Diagnostic services
  • Biomarker assays for neurological disorders2

Contact Information:

  • Located in Laguna Hills, California
  • Email: michael.hull@nvector.com2

Hull brings significant expertise in helping start-ups scale their operations and translate scientific research into marketable technologies, particularly in the life sciences and biotechnology sectors.12

Highlights

Sep 26 · linkedin

Iron Horse Diagnostics receiving The Flinn Foundation's Bioscience Entrepreneurship Award.

Jul 18 · linkedin

We hope the launch of our ALS Diagnostic Test will accelerate a cure to this horrific disease.

Related Questions

What are Michael Hull's key achievements at nVector?
How did Michael Hull transition from InVent Life Sciences to nVector?
What is the significance of nVector's GreenGlia Technology?
How does nVector's technology compare to other CNS gene therapy companies?
What role did Michael Hull play in the rebranding of Iron Horse Diagnostics to nVector?
Michael Hull
Michael Hull, photo 1
Michael Hull, photo 2
Add to my network

Location

Phoenix, Arizona, United States